Análisis de la acción Nature's Sunshine Products Inc (NATR)

Análisis de IA of Nature's Sunshine Products Inc (NATR)

Mantener

Nature's Sunshine Products Inc (NATR) is currently trading at $12.02, significantly below its 52-week high of $28.14, indicating potential for recovery. However, the stock has a low RSI of 28.072, suggesting it is oversold, but the recent earnings miss and lowered guidance raise concerns about future performance. The forward P/E ratio is 8.87, which is attractive, but the net income has been inconsistent, with a recent drop to $3.54 million in Q2 2026. The main risk is the insider selling, which has increased by 161.97% over the last month, indicating lack of confidence among insiders. Therefore, while there is potential for upside, the current market sentiment and risks suggest holding rather than buying at this time.

Métricas de valoración

El PER previsto actual de Nature's Sunshine Products Inc (NATR) es 8.71, frente a su media de 5 años de 12.41.

PER previsto

Valor razonable

Media 5A P/E

12.41

P/E actual

8.71

Sobrevalorada

57.86

Infravalorada

-33.04

EV/EBITDA previsto

Valor razonable

Media 5A EV/EBITDA

6.44

EV/EBITDA actual

3.91

Sobrevalorada

9.12

Infravalorada

3.77

Precio/ventas previsto

Infravalorado

Media 5A P/S

0.62

P/S actual

0.41

Sobrevalorada

0.76

Infravalorada

0.48

Escenarios de precio de Alphio AI para NATR

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%NATR

$16.58

Precio del escenario

B

Base

Base · 50%NATR

$16.06

Precio del escenario

B

Bajista

Bajista · 25%NATR

$14.23

Precio del escenario

Ballenas con NATR en cartera

S

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

+ Con en carteraNATR

-15.12%

Rentabilidad a 3 meses

Preguntas frecuentes sobre NATR, respondidas por Alphio AI

Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk. It operates in the Consumer Non-Cyclicals sector (PHARMACEUTICAL PREPARATIONS industry).

Nature's Sunshine Products Inc (NATR) is currently trading at $12.02, significantly below its 52-week high of $28.14, indicating potential for recovery. However, the stock has a low RSI of 28.072, suggesting it is oversold, but the recent earnings miss and lowered guidance raise concerns about future performance. The forward P/E ratio is 8.87, which is attractive, but the net income has been inconsistent, with a recent drop to $3.54 million in Q2 2026. The main risk is the insider selling, which has increased by 161.97% over the last month, indicating lack of confidence among insiders. Therefore, while there is potential for upside, the current market sentiment and risks suggest holding rather than buying at this time.